SAREPTA THERAPEUTICS INC (SRPT) Stock Income Statement
NASDAQ:SRPT - Nasdaq - US8036071004 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.23B | 1.90B | 1.24B | 933.00M | 701.90M | |||
| Cost Of Goods | 406.10M | 319.10M | 150.34M | 140.00M | 97.00M | |||
| Gross Profit | 1.83B | 1.58B | 1.09B | 793.00M | 604.80M | |||
| Operating Expenses | 1.94B | 1.36B | 1.36B | 1.33B | 1.05B | |||
| Research and Development | 1.38B | 804.52M | 877.39M | 877.10M | 771.20M | |||
| Selling, General, and Administrative Expenses | 564.50M | 557.87M | 481.87M | 451.40M | 282.70M | |||
| Operating Income | -117.21M | 218.08M | -267.82M | -536.20M | -449.70M | |||
| Interest Income/Expense | -73.46M | 4.41M | 13.05M | -30.10M | -56.00M | |||
| Other Income/Expense | 26.48M | 38.29M | 50.33M | 4.30M | -800.00K | |||
| Non Recurring Items | N/A | 0.00 | -315.65M | -128.00M | 87.50M | |||
| Income Before Taxes | -164.19M | 260.77M | -520.10M | -690.00M | -418.90M | |||
| Income Tax | 84.20M | 25.54M | 15.88M | 13.50M | -200.00K | |||
| Net Income | -248.39M | 235.24M | -535.98M | -703.50M | -418.80M | |||
| EBITDA | -78.25M | 255.81M | -223.43M | -494.30M | -411.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.00 | 2.18 | -5.80 | -8.03 | -5.15 | |||
| Non GAAP EPS | -2.69 | 2.28 | -6.12 | -8.03 | -6.01 | |||
| Statistics | ||||||||
| Gross Profit Margin | 81.82% | 83.22% | 87.91% | 84.99% | 86.17% | |||
| Profit Margin | -11.12% | 12.37% | -43.11% | -75.40% | -59.67% | |||
| Operating Profit Margin | -5.25% | 11.47% | -21.54% | -57.47% | -64.07% | |||
All data in USD